Identifying novel therapeutic strategies for metastatic uveal melanoma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2211068
- Recipient
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $564,954
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- San Francisco, CA 94143, USA
Award details come from USAspending.gov.
About this award
The Regents of the University of California, San Francisco will receive $564,954 under a three-year Project Grant from the Department of the Army Medical Command to identify novel therapeutic strategies for metastatic uveal melanoma through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and investigations into medical issues. Specifically, the University of California, San Francisco will conduct research to explore new treatment approaches for metastatic uveal melanoma, a rare but aggressive form of eye cancer that often spreads to other organs. The place of performance is San Francisco, California.
Quick answers
Who received award W81XWH2211068?
W81XWH2211068 was awarded to The Regents Of The University Of California. San Francisco by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2211068 worth?
$564,954 has been obligated on W81XWH2211068.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award